61367-07-5 Usage
Description
Methyl 4-aminocyclohexane-1-carboxylate, also known as Methyl trans-4-aminocyclohexanecarboxylate hydrochloride, is a white crystalline powder with chemical properties that make it a valuable intermediate in pharmaceutical and chemical research. It is a synthetic compound derived from cyclohexane and is known for its potential applications in various industries.
Uses
Used in Pharmaceutical Industry:
Methyl 4-aminocyclohexane-1-carboxylate is used as an intermediate in the synthesis of various pharmaceutical compounds for [application reason]. Its unique chemical structure allows it to be a key component in the development of new drugs and medications.
Used in Chemical Research:
In the field of chemical research, methyl 4-aminocyclohexane-1-carboxylate is used as a starting material for the development of novel chemical compounds and materials. Its versatile structure makes it a valuable tool for researchers in exploring new chemical reactions and applications.
Note: The "application reason" is not provided in the materials, so it is left as a placeholder for the specific reason why this compound is used in the respective industries.
Check Digit Verification of cas no
The CAS Registry Mumber 61367-07-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,3,6 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 61367-07:
(7*6)+(6*1)+(5*3)+(4*6)+(3*7)+(2*0)+(1*7)=115
115 % 10 = 5
So 61367-07-5 is a valid CAS Registry Number.
InChI:InChI:1S/C8H15NO2.ClH/c1-11-8(10)6-2-4-7(9)5-3-6;/h6-7H,2-5,9H2,1H3;1H
61367-07-5Relevant articles and documents
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
-
Page/Page column 95, (2011/02/24)
Compounds of Formula (I) and salts thereof in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
FUSED FURAN COMPOUND
-
Page/Page column 117, (2008/06/13)
The present invention provides a condensed furan compound of the formula (I): wherein Ring X is benzene, pyridine, or the like; Y is an optionally substituted amino, an optionally substituted cycloalkyl, an optionally substituted aryl, an optionally substituted saturated heterocyclic group, an optionally substituted unsaturated heterocyclic group; A is a single bond, lower alkylene, lower alkenylidene, lower alkenylene or an oxygen atom; R3 is hydrogen or the like; and , R4 is hydrogen, or the like, or pharmaceutically acceptable salts thereof, which is useful as a medicament, particularly, as an activated blood coagulation factor X inhibitor.